Back to results
US 2012/0252797 A1Published application
Isoxazole Compounds As Inhibitors Of Heat Shock Proteins
AssigneesVernalis (Cambridge) Limited, The Institute of Cancer Research, Cancer Research Technology Limited
InventorsMartin James Drysdale, Brian William Dymock, Harry Finch, Paul Webb, Edward McDonald, Karen Elizabeth James, Kwai Ming Cheung, Thomas Peter Matthews
Life of this patent
Estimating the term…
Abstract
Isoxazoles of formula (A) or (B) wherein R1 is a group of formula (IB) The isoxazoles are inhibitors of HSP90 activity, and useful for the treatment of, for example, cancers.
Claims34
A compound of formula (A) or (B) or a salt or N-oxide thereof:
- wherein
- R1 is a group of formula (IB)
- wherein:
- R represents one or more optional substituents selected from (C1-C6)alkyl, (C1-C6)alkoxy, hydroxy, hydroxy, (C1-C6)alkyl, halo, trifluoromethyl, trifluoromethoxy, oxo, phenyl, —COOH, —COORA, —CORA—, wherein RA is a (C1-C6)alkyl group,
- Alk1 and Alk2 are optionally substituted divalent C1-C6 alkylene or C2-C6 alkenylene radicals,
- p, r and s are independently 0 or 1,
- Z is —O—, —S—, —(C═O)—, —(C═S)—, —SO2—, —C(═O)O—, —C(═O)NRA—, —C(═S)NRA—, —SO2NRA—, —NRAC(═O)—, —NRASO2— or —NRA— wherein RA is hydrogen or C1-C6 alkyl, and
- Q is hydrogen or an optionally substituted phenyl or pyridinyl radical;
- R2 is (i) a group of formula (IB):
- —Ar1-(Alk1)p-(Z)r-(Alk2)s-Q1 (IB)
- wherein:
- Ar1 is an optionally substituted aryl or heteroaryl radical, and
- Alk1, Alk2, p, r, s, Z, and RA are as defined in relation to R1;
- Q1 is hydrogen or an optionally substituted carbocyclic or heterocyclic radical;
- or
- (ii) a carboxamide radical;
- or
- (iii) a non aromatic carbocyclic or heterocyclic ring wherein a ring carbon is optionally substituted, and/or a ring nitrogen is optionally substituted by a group of formula -(Alk1)p-(Z)r-(Alk2)s-Q1, wherein Alk1, Alk2, Z, p, r and s are as defined above in relation to group of formula (IA) and Q1 is as defined above in relation to group of formula (IB);
- and
- R3 is carboxyl, carboxamide, or carboxyl ester group,
- wherein the term optionally substituted means substituted with up to four substituents selected from (C1-C6)alkyl, (C1-C6)alkoxy, hydroxy, hydroxy(C1-C6)alkyl, mercapto, mercapto(C1-C6)alkyl, (C1-C6)alkylthio, halo, trifluoromethyl, trifluoromethoxy, nitro, nitrile (—CN), oxo, phenyl, —COON, —COORA, —CORA, SO2RA, —CONH2, —SO2NH2, —CONHRA, —SO2NHRA, —CONRARB, —SO2NRARB, —NH2, —NHRA, —NRARB, —OCONH2, —OCONHRA, —OCONRARB, —NHCORA, —NHCOORA, —NRBCOORA, —NHSO2ORA, —NRBSO2OH, —NRBSO2ORA, —NHCONH2, —NRACONH2, —NHCONHRB, —NRACONHRB, —NHCONRARB, or —NRACONRARB wherein RA and RB are independently a (C1-C6)alkyl group.
18 more elements
5-(2,4-Dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-iso-xazole-3-carboxylic acid ethylamide, or a salt thereof.
Dependencies are inferred from the claim text.